Capital Formation
Letters, Testimony & Comments
July 26 2012
Jeffrey S. Hatfield, President and Chief Executive Officer, Vitae Pharmaceuticals
On behalf of the Biotechnology Industry...
March 16 2012
Dear Majority Leader Reid and Minority Leader McConnell:
On behalf of the Biotechnology Industry Organization (BIO) and its more than 1...
March 6 2012
William D. Waddill, Senior Vice President and Chief Financial Officer OncoMed Pharmaceuticals highlights the importance of capital...
December 1 2011
On December 1, BIO submitted written testimony to the Senate Committee on Banking, Housing, and Urban Affairs on the importance of...
April 7 2011
Hearing Testimony
Scott Koenig, M.D., PH.D.
Before the House of Representatives Committee on Small Business
Good morning Chairman...
Press Releases
June 6 2012
Washington, DC and New York, NY, Wednesday, June 6, 2012 -The 4th Annual Scientific American Worldview Report and...
April 5 2012
Washington, D.C. (April 5, 2012) – The Biotechnology Industry Organization expressed strong support for the...
March 22 2012
Washington, DC (March 22, 2012) – The Biotechnology Industry Organization (BIO) applauds the Senate...
December 6 2011
Washington, DC (December 6, 2011) – The Biotechnology Industry Organization (BIO) announces program topics...
November 16 2011
Self-Funding Program Supported by Leading Biotech Trade Associations
WASHINGTON, D.C. (November 16, 2011)...
Receive our newsletter from BIOtechNOW
Business Solutions Sponsor
